Showing results (331-340 of 354) with videos related to
Sort By:
Pageof 36
Cancer Research|June 15, 1992
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate diseaseH B Carter, C H Morrell, J D Pearson, et al.Urology|May 30, 2001
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomyW W Roberts, E J Bergstralh, M L Blute, et al.The New England Journal of Medicine|October 22, 1992
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study GroupG J Gormley, E Stoner, R C Bruskewitz, et al.The Prostate|May 27, 1999
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancerE P Wilkens, D Freije, J Xu, et al.The Journal of Urology|September 24, 1999
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young menJ W Overstreet, V L Fuh, J Gould, et al.The Journal of Urology|October 12, 2000
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancerM L Blute, E J Bergstralh, A W Partin, et al.Prostate Cancer and Prostatic Diseases|January 4, 2017
Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive diseaseJ J Tosoian, R Alam, C Gergis, et al.British Journal of Cancer|January 22, 2004
Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility lociW M Brown, E M Lange, H Chen, et al.British Journal of Cancer|October 17, 2003
Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancerB L Chang, S L Zheng, S D Isaacs, et al.JAMA|October 23, 1997
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locusH Grönberg, S D Isaacs, J R Smith, et al.Pageof 36